title: Interaction of 14-3-3 proteins with the insulin-like growth factor I receptor (IGFIR): evidence for a role of 14-3-3 proteins in IGFIR signaling.
abstract: We have extended our previous yeast two-hybrid findings to show that 14-3-3beta also interacts with the insulin-like growth factor I receptor (IGFIR) in mammalian cells overexpressing both proteins and that the interaction involves serine 1283 and is dependent on receptor activation. Treatment of cells with the phorbol ester PMA stimulates the interaction of 14-3-3beta with the IGFIR in the absence of receptor tyrosine phosphorylation, suggesting that receptor activation leads to activation of an endogenous protein kinase that catalyzes the phosphorylation of serine 1283. To investigate the role of 14-3-3 proteins in IGF signal transduction, IGFIR structure-function studies were performed. Mutation of serine 1283 alone (S1283A) (a mutation that decreases but does not abolish the interaction of the IGFIR with 14-3-3) did not affect anchorage-independent growth of NIH 3T3 fibroblasts overexpressing the mutant receptor. However, the simultaneous mutation of this residue and the truncation of the C-terminal 27 residues of the receptor (Delta1310/S1283A) abolished the interaction of the receptor with 14-3-3 and reversed the enhanced colony formation observed with the IGFIR truncation mutation alone (Delta1310). The difference between the Delta1310 and Delta1310/S1283A transfectants in the soft agar assay was confirmed by tumorigenesis experiments. These findings suggest that 14-3-3 proteins interact with the IGFIR in vivo and that this interaction may play a role in a transformation pathway signaled by the IGFIR.
authors.affiliation: Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
authors.forename: Susan L
authors.initials: SL
authors.lastname: Spence
authors.forename: Bhakta R
authors.initials: BR
authors.lastname: Dey
authors.forename: Cheryl
authors.initials: C
authors.lastname: Terry
authors.forename: Paul
authors.initials: P
authors.lastname: Albert
authors.forename: Peter
authors.initials: P
authors.lastname: Nissley
authors.forename: Richard W
authors.initials: RW
authors.lastname: Furlanetto
mesh_terms: D048948:14-3-3 Proteins; D000818:Animals; D019556:COS Cells / Q000166:cytology; D015197:Carcinogenicity Tests; D002455:Cell Division / Q000502:physiology*; D002522:Chlorocebus aethiops; D006801:Humans; D051379:Mice; D009154:Mutation; D041681:NIH 3T3 Cells / Q000166:cytology; D017526:Receptor, IGF Type 1 / Q000378:metabolism*; D011994:Recombinant Proteins / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D013329:Structure-Activity Relationship; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*
chemical_list: D048948:14-3-3 Proteins; D011994:Recombinant Proteins; C482982:YWHAB protein, human; D014446:Tyrosine 3-Monooxygenase; D017526:Receptor, IGF Type 1; D013755:Tetradecanoylphorbol Acetate